Core Viewpoint - CapBio announced the grant of a patent for a microfluidic chip used for live cell sorting, enhancing the accuracy of cell sorting without damaging the cells, aligning with the company's strategic planning and strengthening its intellectual property system [1] Group 1: Patent Details - The patent titled "A Microfluidic Chip for Live Cell Sorting" was granted in October 2025 [1] - The patent number is 2024203531, awarded by Australia, and the patent rights are held by CapBio and two other companies [1] - This invention is applicable to the company's ongoing projects and has been authorized in multiple regions [1] Group 2: Strategic Implications - The patent aligns with the company's strategic planning, contributing to the enhancement of its core competitiveness [1] - The development of this technology is expected to improve the company's intellectual property framework [1]

Core Viewpoint - On August 1, the company announced the acquisition of multiple invention patents, including a microfluidic chip for live cell sorting, expected to be authorized by July 2025 [2] Group 1 - The company has received authorization for several invention patents [2] - One of the notable patents is for a microfluidic chip designed for live cell sorting [2]